...
首页> 外文期刊>Current Nanomaterials >Morphological Characterization of Lipid Structured Nanoparticles by Atomic Force Microscopy while Minimizing the Formation of Failed Artefacts
【24h】

Morphological Characterization of Lipid Structured Nanoparticles by Atomic Force Microscopy while Minimizing the Formation of Failed Artefacts

机译:原子力显微镜脂质结构纳米粒子的形态学特征,同时最小化形成失效的人工制品

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background: Atomic force microscopy (AFM) is a modern and one the most advanced techniques used in the morphological screening of nanoparticles and other nano and micro biomateri-als. Objective: In this research, we tried to identify the problems and the reasons behind the failed artefacts of the transfersomes made of raloxifene HCl as a model drug, and sodium deoxycholate (anionic), Span 80 and Span 85 (non-ionic) as the surfactants during their characterization by AFM. Method: The critical approach in preparing the test samples for AFM was studied on the mica cover slip. Dynamic light scattering was used to determine the hydrodynamic diameter and zeta potential of the lipid vesicles while high-resolution transmission electron microscopy (HRTEM) was used to measure/determine the particle size. The methods used in the preparation of slides for the lipid-based nano-samples were also summarised in addition to the different materials also used. Results: Hydrodynamic diameter of the formulations was reported as Z-Average values. TSD and TSP-80 formulations showed an average size of 79.96±0.63 and 128.00±0.15 nm, with a PDI of 0.195 and 0.101 with the zeta-potential recorded -17.10±0.21mV and +35.00±0.25mV, respectively. We also observed that the AFM images show a close proximity with HRTEM. AFM shows that external factors such as dilution, selection of slides and preparation of sample led to alteration in the results. Conclusion: AFM characterization was carried out in order to visualise the collapsed and failed artefact due to the use of undefined substrate and methodology. The 3-D images of successful artefact viewed after using suitable conditions clearly showed a distinguished appearance when compared with failed artefact.
机译:背景:原子力显微镜(AFM)是一种现代化的和一种最先进的技术,用于纳米颗粒和其他纳米和微酰胺 - ALS的形态学筛选。目的:在这项研究中,我们试图识别由雷洛昔芬HCl作为模型药物制成的转移术失败的人工制品背后的原因,以及脱氧胆酸钠(阴离子),跨度80和跨度85(非离子)表面活性剂在其特征期间的AFM。方法:在云母盖板上研究了制备AFM测试样品的临界方法。动态光散射用于确定脂质囊泡的流体动力直径和Zeta电位,而高分辨率透射电子显微镜(HRTEM)用于测量/确定粒度。除了也使用的不同材料外,还总结了用于制备基于脂质的纳米样品的载玻片的方法。结果:将配方的流体动力学直径报告为Z平均值。 TSD和TSP-80配方显示平均尺寸为79.96±0.63和128.00±0.15nm,PDI为0.195和0.101,Zeta-Photy录制-17.10±0.21mV和+ 35.00±0.25mV。我们还观察到AFM图像与HRTEM相近。 AFM表明,外部因素如稀释,选择载玻片和样品的制备导致结果改变。结论:进行AFM表征,以便由于使用未定义的基板和方法而可视化塌陷和失效的伪影。使用合适条件后观察的成功人工制品的3-D图像清楚地显示出与失败的人工制品相比的显着外观。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号